AMERICAN INTERNATIONAL GROUP, INC. - DECIPHERA PHARMACEUTICALS IN ownership

DECIPHERA PHARMACEUTICALS IN's ticker is DCPH and the CUSIP is 24344T101. A total of 145 filers reported holding DECIPHERA PHARMACEUTICALS IN in Q4 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.

Quarter-by-quarter ownership
AMERICAN INTERNATIONAL GROUP, INC. ownership history of DECIPHERA PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2023$332,514
-6.3%
26,141
+3.7%
0.00%0.0%
Q2 2023$354,971
-7.9%
25,211
+1.1%
0.00%
-33.3%
Q1 2023$385,277
+8.1%
24,937
+14.7%
0.00%
+50.0%
Q4 2022$356,433
-10.0%
21,747
+1.7%
0.00%
-33.3%
Q3 2022$396,000
+43.0%
21,387
+1.4%
0.00%
+50.0%
Q2 2022$277,000
+51.4%
21,086
+6.8%
0.00%
+100.0%
Q1 2022$183,000
-10.3%
19,738
-5.6%
0.00%0.0%
Q4 2021$204,000
-72.1%
20,915
-2.9%
0.00%
-75.0%
Q3 2021$732,000
-9.3%
21,540
-2.3%
0.00%
+33.3%
Q2 2021$807,000
-20.0%
22,052
-2.0%
0.00%
-25.0%
Q1 2021$1,009,000
-20.2%
22,495
+1.5%
0.00%
-20.0%
Q4 2020$1,265,000
+10.2%
22,166
-0.9%
0.01%
-16.7%
Q3 2020$1,148,000
-16.0%
22,371
-2.2%
0.01%
-14.3%
Q2 2020$1,366,000
+167.3%
22,880
+84.3%
0.01%
+133.3%
Q1 2020$511,000
-33.6%
12,415
+0.4%
0.00%0.0%
Q4 2019$769,000
+89.4%
12,361
+3.2%
0.00%
+50.0%
Q3 2019$406,000
+91.5%
11,972
+27.5%
0.00%
+100.0%
Q2 2019$212,000
+63.1%
9,392
+67.5%
0.00%
Q1 2019$130,000
+7.4%
5,606
-3.1%
0.00%
Q4 2018$121,000
-46.5%
5,787
-0.8%
0.00%
-100.0%
Q3 2018$226,000
+15.9%
5,831
+17.7%
0.00%0.0%
Q2 2018$195,000
+84.0%
4,956
-6.0%
0.00%
Q1 2018$106,000
-15.9%
5,275
-5.1%
0.00%
Q4 2017$126,0005,5580.00%
Other shareholders
DECIPHERA PHARMACEUTICALS IN shareholders Q4 2022
NameSharesValueWeighting ↓
New Leaf Venture Partners, L.L.C. 1,209,571$69,030,00015.95%
SV Health Investors, LLC 449,951$25,679,00012.37%
Sunesis Advisors, LLC 96,299$5,496,0004.45%
Redmile Group, LLC 4,437,968$253,275,0003.07%
Consonance Capital Management LP 484,671$27,660,0002.58%
SECTORAL ASSET MANAGEMENT INC 488,842$27,898,0001.97%
Opaleye Management Inc. 222,000$12,670,0001.66%
Eversept Partners, LP 246,240$14,052,9171.65%
SILVERARC CAPITAL MANAGEMENT, LLC 38,620$2,204,0001.28%
Avoro Capital Advisors LLC 1,300,000$74,191,0001.28%
View complete list of DECIPHERA PHARMACEUTICALS IN shareholders